We have a new study published from our work with the T1D Exchange Quality Improvement Collaborative (QIC) which examines the adoption of telehealth for type 1 diabetes (T1D) care during the COVID-19 pandemic.

In this study, we assess the use of telehealth visits (video or telephone) across the T1D Exchange QIC clinics between December 2019 and August 2020.

The percentage of virtual care visits in QIC clinics before the pandemic was less than 1%, rising to an average of 95.2% in April 2020. By August 2020, the proportion of telehealth visits decreased to an average of 45% across the QIC.

This study highlights the rapid adoption of virtual care in clinics during the pandemic. With these results, future discussion and research topics include insurance reimbursement for telehealth visits, and the ideal ratio of virtual to in-person visits in T1D care.

Read the Full Study: https://www.liebertpub.com/doi/10.1089/dia.2021.0080